Market Cap

Sprint Bioscience AB Market Capitalization:

kr118.6 Million

SEK as of Jan. 1, 2024

US$11.8 Million

business Sprint Bioscience AB Company Profile

Sprint Bioscience AB Main Stock Listing

OMX: SPRINT

Market Capitalization History of Sprint Bioscience AB

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $461.52 B
Vertex Pharmaceuticals Incorporated $107.23 B
Regeneron Pharmaceuticals, Inc. $100.01 B
CSL Limited $94.74 B
Marinomed Biotech AG $73.23 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $586.39 B
UnitedHealth Group $504.47 B
Novo Nordisk $461.52 B
Johnson & Johnson $387.50 B
Merck $296.51 B

Yearly evolution of Sprint Bioscience AB market cap

Date Market Cap YoY Change
Jan. 1, 2024 kr118.6 M 147.14%
Jan. 1, 2023 kr48.0 M -84.70%
Jan. 1, 2022 kr313.6 M -41.29%
Jan. 1, 2021 kr534.1 M -37.57%
Jan. 1, 2020 kr855.6 M -45.43%
Jan. 1, 2019 kr1.57 B 41.75%
Jan. 1, 2018 kr1.11 B -50.48%
Jan. 1, 2017 kr2.23 B -23.72%
Jan. 1, 2016 kr2.93 B 261.95%
Jan. 1, 2015 kr809.0 M

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +269.94%

$10,000 in May 2023 would now be $36,994 by following this algorithm daily at market close.

Boost your stocks returns with Disfold AI... Now!

Try Disfold AI for FREE

Sprint Bioscience AB Categories

Sweden languages Healthcare languages Biotechnology
Sweden Healthcare Sweden Biotechnology

Stocks & Indices

Sprint Bioscience AB has the following listings and related stock indices.


Stock: OMX: SPRINT

Stock: FSX: 5JA1

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.